Cerivastatin, a hydroxymethylglutaryl coenzyme A reductase inhibitor, inhibits cardiac myocyte hypertrophy induced by endothelin
Toshio Nishikimi(Kyoto University), Fumiki Yoshihara(National Cerebral and Cardiovascular Center), H Asakawa(Dokkyo University), Kazumi Akimoto(Dokkyo University), Xin Wang(Shanghai Changning Maternity and Infant Health Hospital), Yosuke Mori(Dokkyo Medical University), Takeshi Horio, Naoto Minamino(National Cerebral and Cardiovascular Center), Kazuyoshi Tadokoro(Dokkyo Medical University)
Cited by 17
Related Papers
Plasma Brain Natriuretic Peptide as a Prognostic Indicator in Patients With Primary Pulmonary Hypertension
|Circulation|2000|880
Plasma Brain Natriuretic Peptide Levels Increase in Proportion to the Extent of Right Ventricular Dysfunction in Pulmonary Hypertension
|Journal of the American College of Cardiology|1998|578
The role of natriuretic peptides in cardioprotection
|Cardiovascular Research|2005|483
Plasma levels of adrenomedullin, a newly identified hypotensive peptide, in patients with hypertension and renal failure.
|Journal of Clinical Investigation|1994|478
Current trends in drug metabolism and pharmacokinetics
|Acta Pharmaceutica Sinica B|2019|391